The studies proposed are designed to investigate two closely related issues: (A) the form, cellular content, and function of the various thyroid hormone receptors and receptor variants and (B) the molecular mechanisms by which thyroid hormone assures normal development of the central nervous system. (A) T3 receptors: Studies within the past four years have established that there are at least four distinctive species of receptors which are coded by two genes, designated alpha1, alpha2, beta1, beta1. Whereas the beta1 receptor appears to be specific for the pituitary, alpha1 and alpha2 have a wider distribution. In contrast to the others, alpha2 forms do not bind T3 since the ligand-binding domain is spliced out of the primary transcript. The development of specific polyclonal antibodies to the alpha2 and beta1 proteins and the application of Western blot techniques have shown even further diversity in size of these receptors. Studies are planned to determine the basis of this heterogeneity whether due to posttranslational modification, multiple translational start sites or other factors. Methods are also proposed to extend these studies to an analysis of the alpha1 receptor and to quantitate the concentration of the various isoforms in tissues and cell lines. The availability of specific antibodies should allow precise measurements of the specific thyroid hormone receptor components in homo- and heterodimers which have been shown to play an important role in thyroid hormone action. The proposed studies should be helpful in clarifying the specific role of the various receptor isoforms in initiating the physiological action of the hormones. (B) Thyroid hormone-dependent development of the central nervous system. Thyroid hormones play a decisive role in normal brain development. Recent studies have shown that a 40-fold surge in the level of the beta1 mRNA occurs in the first 10 neonatal days of rats. This period is coincident with the rise in plasma and tissue T3 and the timing of T3-dependent changes in CNS development. Immunoprecipitation studies have shown that the rise in beta1 mRNA is accompanied by a comparable increase in the beta1 receptor level. Further, immunocytochemical studies have shown a high concentration of beta1 receptor in cerebellar Purkinje cells, consonant with the essential role of thyroid hormones in the normal development of this cell type. Three genes expressed selectively in Purkinje cells have been shown to be regulated either directly or indirectly by T3 in the developmental process. Transient transfection experiments are designed to define the nature of the target gene TREs, the potential role of auxiliary trans- and cis-acting factors, and to determine whether the beta1 receptor plays a unique role in regulating expression. These studies should provide fresh insights not only into the specific mechanism by which thyroid hormones govern brain development but into the general patterns by which other nuclear-acting hormones exert their ontogenic effects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK019812-19
Application #
2137380
Study Section
Endocrinology Study Section (END)
Project Start
1977-03-01
Project End
1997-02-28
Budget Start
1994-03-01
Budget End
1995-02-28
Support Year
19
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Oppenheimer, J H (1999) Evolving concepts of thyroid hormone action. Biochimie 81:539-43
Sandhofer, C; Schwartz, H L; Mariash, C N et al. (1998) Beta receptor isoforms are not essential for thyroid hormone-dependent acceleration of PCP-2 and myelin basic protein gene expression in the developing brains of neonatal mice. Mol Cell Endocrinol 137:109-15
Strait, K A; Carlson, D J; Schwartz, H L et al. (1997) Transient stimulation of myelin basic protein gene expression in differentiating cultured oligodendrocytes: a model for 3,5,3'-triiodothyronine-induced brain development. Endocrinology 138:635-41
Ercan-Fang, S; Schwartz, H L; Oppenheimer, J H (1996) Isoform-specific 3,5,3'-triiodothyronine receptor binding capacity and messenger ribonucleic acid content in rat adenohypophysis: effect of thyroidal state and comparison with extrapituitary tissues. Endocrinology 137:3228-33
Hagen, S G; Larson, R J; Strait, K A et al. (1996) A Purkinje cell protein-2 intronic thyroid hormone response element binds developmentally regulated thyroid hormone receptor-nuclear protein complexes. J Mol Neurosci 7:245-55
Oppenheimer, J H; Braverman, L E; Toft, A et al. (1995) A therapeutic controversy. Thyroid hormone treatment: when and what? J Clin Endocrinol Metab 80:2873-83
Oppenheimer, J H; Schwartz, H L; Strait, K A (1994) Thyroid hormone action 1994: the plot thickens. Eur J Endocrinol 130:15-24
Zou, L; Hagen, S G; Strait, K A et al. (1994) Identification of thyroid hormone response elements in rodent Pcp-2, a developmentally regulated gene of cerebellar Purkinje cells. J Biol Chem 269:13346-52
Schwartz, H L; Strait, K A; Oppenheimer, J H (1993) Molecular mechanisms of thyroid hormone action. A physiologic perspective. Clin Lab Med 13:543-61
Lechan, R M; Qi, Y; Berrodin, T J et al. (1993) Immunocytochemical delineation of thyroid hormone receptor beta 2-like immunoreactivity in the rat central nervous system. Endocrinology 132:2461-9

Showing the most recent 10 out of 21 publications